Collaboration

Mosquito
#Collaboration #Immunology / Virology & Vaccines #Malaria #Recipharm #University of Oxford

Research partners advance two malaria vaccine candidates

The University of Oxford and ReciBioPharm, Recipharm’s Advanced Biologics division, are expanding their long-standing collaboration with the development of two blood-stage malaria vaccine candidates for Phase I/II clinical trials.   Since 2016, the collaboration has delivered five vaccine candidates and will now actively progress the manufacture of R78C… Read More

#News

RNA
#Collaboration #Eli Lilly #Gene therapy #Hearing Loss #RNA

Lilly and Rznomics agree $1.3 billion RNA-editing deal

Eli Lilly has entered into an agreement to develop and commercialise novel RNA-editing therapies using Rznomics' proprietary trans-splicing ribozyme platform.  Rznomics is a clinical-stage biopharmaceutical company based in South Korea focused on developing RNA-based gene therapies.  The collaboration focuses on the discovery and development of RNA-editing therapeutics for sensorineural hearing… Read More

#Business & Investment #News

#Arecor Therapeutics #Collaboration #Obesity #Skye Bioscience #Weight loss

Partners develop enhanced formulation of obesity candidate

Arecor Therapeutics and Skye Bioscience have agreed a formulation development collaboration to develop a novel, higher concentration formulation of Skye’s CB1 inhibitor, nimacimab.  Skye is evaluating nimacimab, a first-in-class CB1-inhibiting monoclonal antibody, in its Phase IIa CBeyond clinical trial in patients with obesity and overweight. Data from the initial 26-week… Read More

#Business & Investment #News

#Cancer research #Cancer vaccines #Collaboration #Immunology / Virology & Vaccines #NHS Cancer Vaccine Launch Pad #Scancell Holdings

In Conversation With: Phil L’Huillier, Scancell

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Phil L’Huillier, CEO of… Read More

#Cancer Research #News

#Clinical trials #Collaboration #Oncology

We need international partnerships to get new cancer drugs into the clinic

On International Clinical Trials Day, Lars Erwig, Director of the Centre for Drug Development at Cancer Research UK, calls for an international approach to clinical trials.  Launching a clinical trial for a new cancer treatment is a formidable challenge. For one thing, patient recruitment is arguably more difficult now than… Read More

#Cancer Research #Exclusive Content #Opinion

#Artificial intelligence (AI) #Benchling #Collaboration #Moderna

Moderna and Benchling collaborate on AI-driven research

Moderna and Benchling have extended their collaboration into a broader rollout across the company’s research organisation.   The expansion will bring hundreds of Moderna’s scientists onto a unified, AI-ready research and development digital platform designed to accelerate discovery and innovation.  “Moderna was built on the belief that technology and science together… Read More

#Business & Investment #News

Indonesian and Scottish flags
#Cancer Research UK #Collaboration #Indonesia #Oncology #Scotland

Indonesia-Scotland cancer research partnership signed

The Ministry of Health of the Republic of Indonesia and the CRUK Scotland Institute have entered into a landmark partnership to advance cancer research, build capacity in cancer care, and support evidence-based health policies through the signing of a Memorandum of Understanding (MoU).  Dr Susanti Susanti, an… Read More

#Cancer Research #News

AAV virus
#AAV #Biotech #Collaboration #Oncology

Partners advance virus-like particle platform for liver cancer

Hovione and Firstgene Life Sciences have announced a strategic collaboration to advance Hovione’s proprietary virus-like particle drug delivery platform for the targeted treatment of Hepatocellular Carcinoma (HCC), a therapeutic indication developed by Firstgene.  Under the terms of the collaboration, Hovione will grant Firstgene an exclusive license to its proprietary novel… Read More

#Business & Investment #News

Tumour microenvironment
#Collaboration #Genetics / genomics #Oncology #Solid tumours

AACR data shows promise for patients with solid tumour types

Data from the Friends of Cancer Research’s (Friends’) ctMoniTR Project, recently published in Clinical Cancer Research (CCR), demonstrate a strong association between changes in levels of circulating tumour DNA (ctDNA) and treatment outcomes. This offers the potential for integration of ctDNA analysis in therapeutic development programmes, and clinical cancer… Read More

#Cancer Research #News

#Collaboration #Immunology / Virology & Vaccines #Longevity #Partnership #Protein chemistry / Proteomics #RNA sequencing

New DDW Highlights podcast: 22 April 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week of financial uncertainty for the industry, our round-up focuses on the… Read More

#News

#Collaboration #Immunology / Virology & Vaccines #Longevity #Partnership #Protein chemistry / Proteomics #RNA sequencing

This week in drug discovery (14-18 April) 

News round-up for 14-18 April by DDW Senior Digital Content Editor Diana Spencer. In a week of financial uncertainty for the industry, our round-up focuses on the power of partnership to accelerate drug discovery, from the prevention of respiratory infections, to mapping gene activity in inflammatory bowel disease. Read More

#News

RNA
#Collaboration #Inflammatory Bowel Disease #PacBio #RNA sequencing #Wellcome Sanger Institute

RNA mapping project focuses on inflammatory bowel disease

Scientists at the Wellcome Sanger Institute in collaboration with Pacific Biosciences (PacBio) have launched a new initiative to map how gene activity shapes the immune system.  It is hoped that the project will identify new therapeutic targets for conditions such as inflammatory bowel disease (IBD). … Read More

#News

Protein degradation
#Boehringer Ingelheim #Collaboration #PROTAC #Protein degradation #University of Dundee

Collaboration award for Dundee PROTAC drug discovery project

A research team at the University of Dundee have been recognised for their work with industry partner, Boehringer Ingelheim, with the Biochemical Society’s 2026 Industry and Academic Collaboration Award.  The award ‘recognises and promotes an outstanding individual or team who has made an inspirational contribution to the… Read More

#News

Influenza virus
#Collaboration #Ethris #Lonza #mRNA #mRNA-based vaccines #Respiratory

Partners develop non-invasive mRNA vaccines

Ethris and Lonza have announced a collaboration to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates.  The vaccines are designed for mucosal delivery and offer a promising approach to combat respiratory diseases.  Room-temperature stability aims to address significant supply chain challenges associated with some… Read More

#News

#Collaboration #Drug discovery #Partnership

The new industry partnerships fuelling innovation

Several new drug discovery collaboration agreements have recently been announced.  Entos Pharmaceuticals and Circio Circio Holding and Entos Pharmaceuticals have revealed plans to jointly develop Circio’s optimised circular RNA expression vectors (circVec) using the Entos Fusogenix PLV nucleic acid delivery technology.   Under the collaboration, Entos will develop and validate PLV-formulations… Read More

#Business & Investment #News

Monoclonal antibodies
#Antibodies #Biotechnology #Collaboration #Drug development #Drug discovery #Pierre Fabre Laboratories #RedRidge

Pharma/biotech biparatopic antibody collaboration agreed

Pierre Fabre Laboratories and RedRidge have announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic antibody (BPA) drug candidates against multiple targets. In line with Pierre Fabre Laboratories’ innovation strategy, the partnership’s therapeutic focus will be on precision oncology as well as dermatology and rare diseases. Read More

#News